GenAI Expansion CapeStart is actively expanding its GenAI capabilities and global delivery footprint, including a new AI Center of Excellence in Chennai, India. This presents a sales opportunity to engage enterprise clients in healthcare, life sciences, telecom, finance, retail, manufacturing, and legal sectors seeking scalable GenAI and data annotation solutions.

Clinical Life Sciences With a strong focus on life sciences and medical imaging annotation across X-ray, MRI, CT, PET, and ultrasound, there is potential to upsell end-to-end AI/ML data operations, regulatory support, and custom software for clinical documentation and regulatory submissions to pharma and CROs.

MadeAi Platform MadeAi, a GenAI-based platform for synthesizing content and data, positions CapeStart as a strategic partner for clients needing accelerated model training, data generation, and regulatory-ready outputs — a compelling value proposition for healthcare providers, biotech firms, and life sciences researchers.

Awarded credibility Industry recognition such as Stevie awards and an Exceptional Employee Experience accolade bolster CapeStart’s credibility with potential customers and talent-driven organizations, enabling easier outreach to risk-averse enterprises prioritizing proven technology partners.

Global delivery With headquarters in the US and delivery centers in India, plus activity across the Middle East and Asia and a growing client base of over 100 organizations, CapeStart can target global enterprises seeking nearshore/offshore models, scale, and diverse regional support.